Instalimb Gains Investment from UTokyo IPC for Global Expansion
Deal News | Mar 26, 2025 | UTokyo Innovation Platform Co
UTokyo Innovation Platform Co., Ltd. (UTokyo IPC), through its AOI Fund I, has announced investment in Instalimb Inc., a startup based in Tokyo specializing in affordable prosthetics using 3D printing and AI technology. This investment is part of a Series B extension round with participation from eight other investors. Instalimb aims to address the prosthetic needs of over 40 million people worldwide, especially in developing countries where health checkups are rare and conventional prosthetic limbs are costly. The company has leveraged technology to enhance manufacturing efficiency, producing over 5,000 prosthetic limbs in India and the Philippines, with global expansion plans underway. The support of UTokyo IPC aligns with its broader mission of solving deep social challenges through innovation, especially in countries with acute demand for accessible prosthetics such as India, Indonesia, Ukraine, and Nigeria.
Sectors
- Medical Technology
- Venture Capital
Geography
- Japan – Both UTokyo IPC and Instalimb Inc. are based in Japan.
- India – Instalimb's manufacturing facilities are located in India, and the company operates here as well.
- Philippines – Instalimb also delivers solutions in the Philippines, reflecting its operational presence.
- Indonesia, Ukraine, Nigeria – Future expansion plans for Instalimb include these countries where demand for prosthetics is high.
Industry
- Medical Technology – Instalimb Inc. operates in the medical technology sector by utilizing 3D printing and AI to create affordable prosthetics.
- Venture Capital – UTokyo IPC's investment in Instalimb represents a venture capital activity, supporting startups and innovation.
Financials
- Series B extension round – The round in which UTokyo IPC and other investors participated to fund Instalimb.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| UTokyo Innovation Platform Co., Ltd. | Investing Company | Company | Provides venture support through its AOI Fund I, focusing on open innovation and startup investments. |
| Instalimb Inc. | Target Company | Company | A medical technology startup specializing in 3D printed and AI-optimized affordable prosthetics. |
| AOI Fund I | Investment Fund | Company | Part of UTokyo IPC, focusing on fostering startups through academic and corporate collaboration. |
| Kosuke Ueda | President & CEO of UTokyo IPC | Person | Leader of the UTokyo Innovation Platform overseeing investments and open innovation initiatives. |
| Yutaka Tokushima | CEO of Instalimb Inc. | Person | Leader of the medtech startup Instalimb, pushing forward the mission for accessible prosthetics. |
| Nako Kawashima | Investment Manager | Person | Investment Manager at UTokyo IPC who commented on the strategic alignment of the Instalimb investment. |
| JIC Venture Growth Investments Co., Ltd. | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| Mizuho Capital Co., Ltd. | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| IT-Farm Corporation | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| MIRAISOZO INVESTMENTS Inc. | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| Shinkin Capital Co.,Ltd. | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| Rebright Partners Pte Ltd. | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| Darwin Venture Management Corporation | Investor | Company | One of the investors in Instalimb's Series B extension round. |
| Kyocera Venture Fund | Investor | Company | One of the investors in Instalimb's Series B extension round. |